NPI: 1164495255 · HICKORY, NC 28602 · General Acute Care Hospital · NPI assigned 02/09/2006
Authorized official GALLAGHER, PAMELA controls 20+ related entities in our dataset. Read more
| Authorized Official | GALLAGHER, PAMELA (VP OF FINANCE) |
| NPI Enumeration Date | 02/09/2006 |
Other providers sharing the same authorized official: GALLAGHER, PAMELA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 57,205 | $1.85M |
| 2019 | 55,072 | $1.83M |
| 2020 | 33,288 | $1.16M |
| 2021 | 53,256 | $2.46M |
| 2022 | 58,652 | $3.66M |
| 2023 | 57,752 | $3.26M |
| 2024 | 55,217 | $3.14M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 20,211 | 17,902 | $5.24M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 34,560 | 31,557 | $5.14M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,182 | 3,798 | $1.17M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 5,066 | 2,306 | $712K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,201 | 3,728 | $631K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,058 | 4,683 | $447K |
| 71046 | Radiologic examination, chest; 2 views | 7,872 | 7,385 | $324K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 3,224 | 2,681 | $321K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 39,872 | 35,118 | $319K |
| J3490 | Unclassified drugs | 96,322 | 39,257 | $319K |
| 80053 | Comprehensive metabolic panel | 28,656 | 25,564 | $267K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,948 | 6,180 | $267K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,310 | 5,550 | $207K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,160 | 1,048 | $204K |
| 41899 | Unlisted procedure, dentoalveolar structures | 155 | 126 | $174K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 323 | 302 | $171K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,214 | 1,738 | $120K |
| 36415 | Collection of venous blood by venipuncture | 34,049 | 29,308 | $81K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,916 | 2,613 | $78K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,325 | 1,105 | $74K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,378 | 2,217 | $64K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,379 | 2,218 | $64K |
| 76819 | Fetal biophysical profile; without non-stress testing | 934 | 588 | $61K |
| 70450 | Computed tomography, head or brain; without contrast material | 289 | 273 | $50K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,317 | 1,214 | $50K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 805 | 784 | $48K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,546 | 1,417 | $47K |
| 86780 | 2,923 | 2,617 | $46K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,690 | 2,288 | $44K |
| 80061 | Lipid panel | 2,482 | 2,364 | $44K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 826 | 697 | $43K |
| 81001 | 12,319 | 10,854 | $39K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,886 | 1,720 | $39K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 436 | 230 | $29K |
| 76820 | 276 | 122 | $28K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 281 | 147 | $28K |
| 84484 | 2,648 | 2,294 | $21K | |
| 86762 | 1,211 | 1,074 | $19K | |
| 86787 | 1,328 | 1,177 | $19K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 99 | 99 | $18K |
| J7050 | Infusion, normal saline solution, 250 cc | 2,391 | 1,021 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,821 | 1,602 | $16K |
| 87653 | 588 | 550 | $16K | |
| 86850 | 1,354 | 1,197 | $15K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 525 | 433 | $14K |
| 83690 | 1,982 | 1,736 | $14K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,683 | 1,327 | $12K |
| 87522 | Neg quan hep c or qual rna | 367 | 300 | $12K |
| 87536 | 180 | 163 | $12K | |
| 87340 | 1,122 | 997 | $11K | |
| Q3014 | Telehealth originating site facility fee | 1,188 | 790 | $10K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 42 | 41 | $10K |
| 87071 | 815 | 778 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 390 | 344 | $8K |
| 83021 | 444 | 406 | $8K | |
| 71045 | Radiologic examination, chest; single view | 231 | 210 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 12 | 12 | $7K |
| 80320 | 325 | 304 | $7K | |
| 86803 | 365 | 300 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 553 | 505 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 136 | 129 | $6K |
| 87150 | 192 | 183 | $6K | |
| 82950 | 1,064 | 989 | $5K | |
| 11045 | 76 | 36 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 792 | 705 | $5K |
| 81025 | 533 | 457 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 125 | 111 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | 70 | 64 | $4K |
| 87430 | 227 | 210 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 180 | 152 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 64 | 58 | $3K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 696 | 259 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 51 | 51 | $2K |
| 82607 | 81 | 74 | $2K | |
| 87486 | 45 | 44 | $2K | |
| 86900 | 1,252 | 1,115 | $2K | |
| 93798 | 89 | 12 | $2K | |
| 87581 | 45 | 44 | $2K | |
| 86901 | 1,252 | 1,115 | $2K | |
| 84480 | 81 | 74 | $2K | |
| 86361 | 38 | 37 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 45 | 44 | $1K |
| 73630 | 22 | 15 | $1K | |
| 85660 | 227 | 208 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 879 | 718 | $1K |
| 84439 | 76 | 69 | $1K | |
| 88142 | 30 | 27 | $889.39 | |
| 83020 | 48 | 42 | $863.53 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 321 | 283 | $789.81 |
| 94375 | 12 | 12 | $672.36 | |
| 82728 | 34 | 32 | $624.23 | |
| 94727 | 12 | 12 | $592.74 | |
| 84702 | 55 | 36 | $547.56 | |
| 83655 | 44 | 40 | $542.88 | |
| 83540 | 44 | 42 | $424.01 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 40 | 39 | $400.78 |
| 83550 | 28 | 28 | $373.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 149 | 111 | $356.41 |
| 96367 | 18 | 12 | $354.36 | |
| 94150 | 12 | 12 | $331.61 | |
| 82746 | 12 | 12 | $287.33 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 81 | 65 | $214.09 |
| 85610 | 65 | 60 | $202.90 | |
| 80050 | General health panel | 13 | 13 | $141.96 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 43 | 22 | $132.37 |
| 81002 | 722 | 595 | $119.04 | |
| 87186 | 13 | 12 | $118.47 | |
| 84436 | 17 | 16 | $113.02 | |
| 87077 | 13 | 12 | $110.66 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 13 | 12 | $104.95 |
| 84703 | 20 | 12 | $101.11 | |
| A9270 | Non-covered item or service | 18 | 13 | $19.55 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 47 | 24 | $17.16 |
| 99464 | 23 | 13 | $0.00 | |
| 59025 | Fetal non-stress test | 68 | 51 | $0.00 |
| 59899 | 34 | 32 | $0.00 |